APA

Shorter E., Whiteside M., Harthan J., Margolis M. S., Hartwick A. T., Johnson S., Migneco M., Morettin C., Olson C. K., Huecker J., Than T. & Gordon M. O. (20201208). Safety and tolerability of a one-time, in-office administration of 5% povidone-iodine in the treatment of adenoviral conjunctivitis: The Reducing Adenoviral Patient Infected Days (RAPID) study. : The ocular surface.

Chicago

Shorter Ellen, Whiteside Meredith, Harthan Jennifer, Margolis Mathew S, Hartwick Andrew T, Johnson Spencer, Migneco Mary, Morettin Christina, Olson Christian K, Huecker Julia, Than Tammy and Gordon Mae O. 20201208. Safety and tolerability of a one-time, in-office administration of 5% povidone-iodine in the treatment of adenoviral conjunctivitis: The Reducing Adenoviral Patient Infected Days (RAPID) study. : The ocular surface.

Harvard

Shorter E., Whiteside M., Harthan J., Margolis M. S., Hartwick A. T., Johnson S., Migneco M., Morettin C., Olson C. K., Huecker J., Than T. and Gordon M. O. (20201208). Safety and tolerability of a one-time, in-office administration of 5% povidone-iodine in the treatment of adenoviral conjunctivitis: The Reducing Adenoviral Patient Infected Days (RAPID) study. : The ocular surface.

MLA

Shorter Ellen, Whiteside Meredith, Harthan Jennifer, Margolis Mathew S, Hartwick Andrew T, Johnson Spencer, Migneco Mary, Morettin Christina, Olson Christian K, Huecker Julia, Than Tammy and Gordon Mae O. Safety and tolerability of a one-time, in-office administration of 5% povidone-iodine in the treatment of adenoviral conjunctivitis: The Reducing Adenoviral Patient Infected Days (RAPID) study. : The ocular surface. 20201208.